Loading financials from SEC filings…
Medical care facilities · Healthcare · Fiscal year ends Dec 31
Concentra Group Holdings Parent reported revenue of $2.2B in the fiscal year ended Dec 2025, up 13.9% from the year before. Operating income was $334M, an operating margin of 15.4%, and net income was $166M. Operating cash flow of $279M less capital expenditure of $82M left free cash flow of $197M. Net debt was $1.5B.
Ranks among the 24 medical care facilities companies we cover (1st = best; for debt, the least indebted). Green = top third, red = bottom third.
Last 5 fiscal years
| Fiscal year | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Revenue | 1,724 | 1,838 | 1,900 | 2,163 |
| Cost of revenue | 1,242 | 1,326 | 1,372 | 1,550 |
| Gross profit | 482 | 512 | 528 | 613 |
| Operating income | 259 | 288 | 305 | 334 |
| Interest expense | 0.8 | 0.2 | 47.7 | 109 |
| Pre-tax income | 225 | 243 | 231 | 224 |
| Income tax | 52.7 | 57.9 | 59.5 | 51.0 |
| Net income | 167 | 180 | 167 | 166 |
| Diluted EPS | 1.60 | 1.73 | 1.46 | 1.30 |
| Diluted shares | 104 | 104 | 114 | 128 |
| Fiscal year | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Cash & equivalents | 37.7 | 31.4 | 183 | 79.9 |
| Receivables | – | 216 | 218 | 258 |
| Current assets | – | 294 | 437 | 383 |
| Net PP&E | – | 178 | 198 | 225 |
| Goodwill | 1,226 | 1,230 | 1,235 | 1,479 |
| Total assets | 2,297 | 2,334 | 2,521 | 2,858 |
| Payables | – | 20.4 | 19.8 | 21.0 |
| Current liabilities | – | 275 | 307 | 337 |
| Long-term debt | – | 3.3 | 1,469 | 1,564 |
| Total liabilities | 1,318 | 1,156 | 2,222 | 2,438 |
| Shareholders' equity | 979 | 1,161 | 276 | 393 |
| Fiscal year | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Operating cash flow | 274 | 234 | 275 | 279 |
| Capital expenditure | 46.0 | 65.0 | 64.3 | 82.3 |
| Free cash flow | 228 | 169 | 210 | 197 |
| Depreciation & amortisation | 73.7 | 73.1 | 67.2 | 75.8 |
| Stock-based compensation | 2.1 | 0.7 | 2.3 | 10.5 |
| Acquisitions | 9.7 | 6.0 | 7.0 | 333 |
| Share buybacks | 0.0 | 0.0 | 15.4 | 22.4 |
| Dividends paid | 0.0 | 0.0 | 8.0 | 32.1 |
| Dividend per share | – | – | 0.06 | 0.25 |
| Fiscal year | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Revenue growth (YoY) | – | 6.6% | 3.4% | 13.9% |
| Operating income growth (YoY) | – | 11.3% | 6.0% | 9.6% |
| EPS growth (YoY) | – | 8.1% | −15.6% | −11.0% |
| Gross margin | 27.9% | 27.9% | 27.8% | 28.3% |
| Operating margin | 15.0% | 15.6% | 16.0% | 15.4% |
| Net margin | 9.7% | 9.8% | 8.8% | 7.7% |
| Return on equityBlank when equity is negative | 17.0% | 15.5% | 60.4% | 42.3% |
| ROCEEBIT ÷ (assets − current liabilities) | – | 14.0% | 13.8% | 13.2% |
| Free cash flow margin | 13.2% | 9.2% | 11.1% | 9.1% |
| Cash conversion (CFO ÷ net income) | 1.65x | 1.30x | 1.65x | 1.68x |
| Receivable days | – | 43 | 42 | 44 |
| Payable days | – | 6 | 5 | 5 |
| Interest cover | 305x | 1302x | 6.39x | 3.06x |
| Debt ÷ equity | – | 0.00x | 5.33x | 3.98x |
| Net debtDebt − cash & equivalents; excludes investments; negative = net cash | – | −28.1 | 1,286 | 1,484 |
| Current ratio | – | 1.07x | 1.42x | 1.14x |
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.